SunFire Biotechnologies
Birmingham
About SunFire Biotechnologies
SunFire Biotechnologies is a contract research organization formed by a group with extensive experience in pneumococcal vaccine evaluations. SunFire offers testing for antibodies against the pneumococcal serotypes found in existing and developing pneumococcal vaccines, as well as for immunoassays for other bacterial species (such as GBS and Shigella).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.0M
- Last round: Grant (Aug 2022)
- Website: sunfirebio.com
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/sunfire-biotechnologies-116334 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.